BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

EuropCR 2015 Interview, Part II: Philips-Volcano combo combo to clear competitors in cath lab

May 26, 2015
By John Brosky

EuroPCR Interview, Part 1: Acquiring Volcano brings Philips 'intimacy' in $4 billion market

May 22, 2015
By John Brosky
PARIS — After selling its lighting division, Royal Philips (Amsterdam, the Netherlands) made a strategic decision to expand its healthcare division as a stand-alone business. In December 2014, Philips announced it would pay $1.2 billion to acquire Volcano Corporation (San Diego), a leader in the fast-growing interventional cardiology segment.
Read More

EuroPCR notebook: Edwards pauses enrollment in FORTIS mitral valve program

May 21, 2015
By John Brosky

Renal Denervation Resurrected: After clinical setbacks, renal denervation reboots with clinicians taking the lead

May 21, 2015
By John Brosky
PARIS — The launch of renal denervation for the control of resistant hypertension is destine to become a textbook case study in how not to market a medical device.
Read More

EuroPCR 2015: Looking beyond cardiology, heart 'operators' eye stroke intervention

May 20, 2015
By John Brosky
PARIS — Calling all interventional cardiologists. Your skills are needed in brain surgery. Stat! Stopping short of a general alarm, the EuroPCR (Paris Course on Revascularization; Paris) organization has formally issued a call to action to mobilize its growing army of interventional cardiologists to help organize stroke intervention centers.
Read More

Report from Europe: Northern Europe best entry point for mobile health apps

May 18, 2015
By John Brosky

MDD Interview: NextStim targets $1.8B with brain stimulation for stroke therapy

May 13, 2015
By John Brosky

Report from Europe: Carmat's 2nd patient dies due to artificial heart dysfunction

May 11, 2015
By John Brosky
PARIS — The second patient to receive a fully implantable artificial heart made by Carmat (Paris) died May 2, after a rescue operation at the University Hospital Center (Nantes, France) aimed at replacing a malfunctioning heart that had kept him alive for nine months (Medical Device Daily, May 7, 2015).
Read More

IVD evidence a key to compliance with revised CE mark rules

April 17, 2015
By John Brosky

Report from Europe: Latvia forces breakout of CE mark reform from Council stalemate

April 16, 2015
By John Brosky
View All Articles by John Brosky

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 15, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing